U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Zonisamide (marketed as Zonegran) Information
  1. Postmarket Drug Safety Information for Patients and Providers

Zonisamide (marketed as Zonegran) Information

Zonisamide (marketed as Zonegran) is a prescription medicine that is used with other medications to treat partial seizures in adults.
 

To report any unexpected adverse or serious events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.

Related Information

Labeling and Regulatory History from Drugs@FDA

Back to Top